Progesterone Microspheres Pharmacokinetic - Pharmacodynamic (PK-PD) Study

Mise à jour : Il y a 4 ans
Référence : NCT01176175

Femme Homme

  • | Pays :
  • Mexico
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Phase: I pharmacokinetic - pharmacodynamic (PK-PD) study. Main objective: To establish the minimum effective dose of progesterone microspheres suspension, which administered by weekly intramuscular injection, will be able to induce transformation from a proliferative endometrium to a secretory endometrium. Study design: Randomized, controlled, open-label, parallel, dose-response clinical trial. Sites: 1 Subjects: 48 postmenopausal women.


Critère d'inclusion

  • Infertility

Liens